Details of Disease

Disease Name

Corpus callosum, agenesis of

ACC; agenesis of the corpus callosum; isolated corpus callosum agenesis; agenesis of corpus callosum; corpus callosum agenesis; corpus callosum, agenesis of

Definition

A congenital abnormality characterized by the complete absence of the corpus callosum. It may be an isolated abnormality or associated with other central nervous system abnormalities or syndromes. Clinical manifestations vary. In cases of isolated corpus callosum agenesis, symptoms may be absent or minimal. In cases that are associated with other central nervous system abnormalities or syndromes, symptoms include developmental delays, motor coordination difficulties, and vision impairment.

Disease Hierarchy

DIS2BIP8: Congenital nervous system disorder

DISD715V: Hereditary neurological disease

DISO9P40: Corpus callosum, agenesis of

Disease Identifiers

MONDO ID

MONDO_0009022

MESH ID

D061085

UMLS CUI

C0175754

OMIM ID

217990

MedGen ID

104498

HPO ID

HP:0001274

Orphanet ID

200

SNOMED CT ID

5102002

General Information of Disease (ID: DISO9P40)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 49 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ACTG1	TTGAZF9	Limited	Biomarker	[1]
BBC3	TT7JUKC	Limited	Altered Expression	[2]
CREBBP	TTFRCTK	Limited	Posttranslational Modification	[3]
CYP11A1	TTSYVO6	Limited	Genetic Variation	[4]
CYP11B1	TTIQUX7	Limited	Biomarker	[5]
DGKZ	TTSBBXL	Limited	Biomarker	[6]
DHCR24	TTTK0NH	Limited	Posttranslational Modification	[7]
DKK3	TTY2ZV6	Limited	Biomarker	[8]
EHMT1	TTOFXD7	Limited	Altered Expression	[9]
FCGR1A	TTZK4I3	Limited	Biomarker	[10]
FSCN1	TTTRS9B	Limited	Biomarker	[11]
HCN2	TT9EUT4	Limited	Biomarker	[12]
HSD17B4	TTL1WGS	Limited	Altered Expression	[13]
LHCGR	TT2O4W9	Limited	Biomarker	[14]
LONP1	TTM1VPZ	Limited	Altered Expression	[15]
LY96	TT8S9AV	Limited	Altered Expression	[16]
NNT	TTKIH76	Limited	Biomarker	[17]
PCYT1B	TTUAIKM	Limited	Genetic Variation	[18]
PRKACA	TT5U49F	Limited	Genetic Variation	[19]
RAB7A	TTF6WAQ	Limited	Genetic Variation	[20]
SLC25A1	TTTD730	Limited	Genetic Variation	[21]
SLC40A1	TT6Y1PG	Limited	Altered Expression	[22]
SOX2	TTCNOT6	Limited	Biomarker	[23]
SPOCK1	TTF23RE	Limited	Genetic Variation	[24]
UBC	TTBP3XA	Limited	Biomarker	[25]
ASIC2	TTVMWLP	moderate	Altered Expression	[26]
GAA	TTLPC70	moderate	Genetic Variation	[27]
HDC	TTV9GOF	moderate	Altered Expression	[28]
HRH3	TT9JNIC	moderate	Altered Expression	[28]
ZEB2	TTT2WK4	moderate	Biomarker	[29]
ACACB	TTY84UG	Strong	Biomarker	[30]
ADK	TTL732K	Strong	Genetic Variation	[31]
BCL2A1	TTGT9C7	Strong	Biomarker	[30]
BIRC7	TTHZ8TA	Strong	Altered Expression	[32]
CDA	TTQ12RK	Strong	Biomarker	[33]
CDH2	TT1WS0T	Strong	Genetic Variation	[34]
ESRRA	TTPNQAC	Strong	Altered Expression	[35]
GLI2	TT045OH	Strong	Biomarker	[36]
IGF2	TTE8WGO	Strong	Biomarker	[37]
KAT6B	TTH4VJL	Strong	CausalMutation	[38]
L1CAM	TTC9D3K	Strong	Genetic Variation	[39]
NAGLU	TTDM6HZ	Strong	Biomarker	[32]
PDE11A	TTTWC79	Strong	Genetic Variation	[40]
RTN4R	TTVRZUO	Strong	Biomarker	[41]
RUNX3	TTKCVO7	Strong	Altered Expression	[42]
SLC12A6	TT8DFHE	Strong	Genetic Variation	[43]
TOP2A	TTCGY2K	Strong	Altered Expression	[44]
AKT3	TTO6SGY	Definitive	Biomarker	[45]
MC2R	TTPWFDX	Definitive	Biomarker	[46]
------------------------------------------------------------------------------------


⏷ Show the Full List of 49 DTT(s)

This Disease Is Related to 1 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
ABCD1	DTKM9DZ	Strong	Genetic Variation	[47]
------------------------------------------------------------------------------------

This Disease Is Related to 2 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
SULT2A1	DE0P6LK	Limited	Biomarker	[48]
HINT1	DEWJATF	Definitive	Biomarker	[49]
------------------------------------------------------------------------------------

This Disease Is Related to 99 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACACA	OT5CQPZY	Limited	Posttranslational Modification	[50]
ACADVL	OT50L4XB	Limited	Altered Expression	[51]
ACOT7	OT7C68YV	Limited	Biomarker	[1]
ACTBL2	OTD6B81U	Limited	Biomarker	[1]
ACTG2	OTRDWUO0	Limited	Biomarker	[1]
ALOX15B	OTWQQ08W	Limited	Altered Expression	[51]
ARID1B	OTILK3Q7	Limited	Genetic Variation	[52]
BARD1	OTTC0Z9Y	Limited	Altered Expression	[53]
BCL9	OTRBIPR4	Limited	Altered Expression	[54]
BMS1	OTEGQ8ZO	Limited	Posttranslational Modification	[50]
BUB1B	OT8KME51	Limited	Biomarker	[55]
CDK5RAP2	OTRKEVTY	Limited	Autosomal recessive	[56]
CORO7	OTG7MEAJ	Limited	Biomarker	[57]
CTBS	OT135K92	Limited	Genetic Variation	[18]
DCUN1D1	OT8UJLZU	Limited	Altered Expression	[58]
DDT	OTF5HTYL	Limited	Biomarker	[59]
DDX23	OTBJHS8C	Limited	Genetic Variation	[60]
DISC1	OT43AW4H	Limited	Genetic Variation	[61]
DNAH8	OTGES2OU	Limited	Biomarker	[62]
EN1	OT2DKIDK	Limited	Biomarker	[63]
EPG5	OT3P5HQD	Limited	Biomarker	[64]
FABP7	OTRE2H4G	Limited	Altered Expression	[65]
FATE1	OTPYXV64	Limited	Altered Expression	[66]
FHL5	OT6C00Z1	Limited	Biomarker	[1]
FOXG1	OTAW57J4	Limited	Genetic Variation	[67]
GARS1	OT5B6R9Y	Limited	Genetic Variation	[20]
GPX4	OTRAFFX2	Limited	Altered Expression	[59]
HMSD	OTGR7BCP	Limited	Biomarker	[68]
KIF1B	OTI1XQTO	Limited	Genetic Variation	[20]
KREMEN1	OTGJFSAC	Limited	Genetic Variation	[69]
KRT15	OTS6WLF7	Limited	Biomarker	[70]
MAD2L1BP	OT2O2IUJ	Limited	Genetic Variation	[20]
MAML2	OT1TSVAR	Limited	Biomarker	[71]
MED27	OT40PZ9R	Limited	Altered Expression	[72]
MKS1	OT83W5PB	Limited	Genetic Variation	[73]
MRAP2	OTCQS7DB	Limited	Altered Expression	[74]
NECTIN1	OTTE5ZR6	Limited	Biomarker	[75]
NR5A1	OTOULYR4	Limited	Biomarker	[11]
NUMA1	OTTKAVG4	Limited	Biomarker	[75]
OBP2A	OTBIJ5TI	Limited	Biomarker	[76]
PA2G4	OT7IG7HT	Limited	Biomarker	[77]
POTEM	OT7L2HGH	Limited	Biomarker	[1]
RARRES2	OT1BJE8K	Limited	Biomarker	[78]
RFX3	OTE0EI8Z	Limited	Biomarker	[79]
SBSN	OT89RKJH	Limited	Biomarker	[80]
SDHB	OTRE1M1T	Limited	Altered Expression	[81]
SERPINA3	OT9BP2S0	Limited	Biomarker	[1]
SFPQ	OTLCIAPJ	Limited	Biomarker	[82]
SKA1	OTDYJ12A	Limited	Biomarker	[83]
SMARCA1	OT0Y6PTU	Limited	Altered Expression	[62]
SMARCA2	OTSGJ8SV	Limited	Biomarker	[62]
SPEN	OT37A2MD	Limited	Genetic Variation	[84]
DAB1	OTPL9MA3	Disputed	Biomarker	[85]
ARX	OTBGYH25	moderate	Genetic Variation	[86]
DCC	OT2C1SHW	moderate	Genetic Variation	[87]
GLYAT	OT3WWYXD	moderate	Genetic Variation	[27]
NAGA	OTNUEUZY	moderate	Biomarker	[88]
NFIA	OTDHQ9CG	moderate	Biomarker	[89]
PRKAB1	OT1OG4QZ	moderate	Biomarker	[90]
PYCR1	OTQHB52T	moderate	Genetic Variation	[91]
SFN	OTLJCZ1U	moderate	Posttranslational Modification	[92]
ALDH18A1	OT6W40XU	Strong	Genetic Variation	[91]
AMPD2	OTBS30JU	Strong	Genetic Variation	[93]
ARHGAP31	OTUYTF4I	Strong	Genetic Variation	[94]
ARMC5	OTO7IV74	Strong	Biomarker	[95]
BCL11B	OT8KKCVJ	Strong	CausalMutation	[96]
CDK10	OTKP7TTR	Strong	Genetic Variation	[97]
DOCK6	OTPNUVLT	Strong	Genetic Variation	[94]
EARS2	OTNCJKY7	Strong	Genetic Variation	[98]
ELAVL2	OT6EJ8MQ	Strong	Altered Expression	[25]
ENOPH1	OTKXMWNN	Strong	Biomarker	[99]
EOGT	OT4A2A8P	Strong	Genetic Variation	[94]
GEMIN2	OT4L6TLL	Strong	Altered Expression	[100]
GLI3	OTKDOE94	Strong	Biomarker	[79]
HOXA6	OTHJP8M2	Strong	Genetic Variation	[101]
INHA	OT7HWCO3	Strong	Genetic Variation	[102]
MEF2C	OTZGF1Y5	Strong	Genetic Variation	[103]
MYBL1	OTBJMC2P	Strong	Altered Expression	[104]
NBAS	OTW9IBRI	Strong	Biomarker	[32]
NCOA1	OTLIUJQD	Strong	Biomarker	[105]
NDRG4	OTJBOTD8	Strong	Altered Expression	[106]
NEFL	OTQESJV4	Strong	Biomarker	[49]
NEUROG3	OT6DIPWC	Strong	Genetic Variation	[107]
PAK3	OT80M3BV	Strong	Genetic Variation	[108]
PELP1	OTVXQNOT	Strong	Biomarker	[109]
PRICKLE1	OT9HHEM9	Strong	Genetic Variation	[110]
PRKAA1	OT7TNF0L	Strong	Biomarker	[90]
PRKAA2	OTU1KZPV	Strong	Biomarker	[90]
RPGRIP1L	OT6Z069I	Strong	Biomarker	[79]
SCAF11	OTX59D0X	Strong	Altered Expression	[100]
SCN7A	OTK05PXY	Strong	Biomarker	[32]
SF1	OTLEDM2S	Strong	Biomarker	[111]
SGTA	OTKOJ3JB	Strong	Genetic Variation	[112]
SIN3A	OTM8OZWV	Strong	Biomarker	[113]
SOX10	OTF25ULQ	Strong	Altered Expression	[114]
TFAP2C	OTUDIW05	Strong	Altered Expression	[115]
TMEM67	OTME92T5	Strong	Genetic Variation	[116]
CYP2U1	OT6RXLXS	Definitive	Biomarker	[49]
MED25	OTDBY87B	Definitive	Biomarker	[49]
------------------------------------------------------------------------------------


⏷ Show the Full List of 99 DOT(s)

References

1	Adrenocortical carcinoma -- improving patient care by establishing new structures.Exp Clin Endocrinol Diabetes. 2006 Feb;114(2):45-51. doi: 10.1055/s-2006-923808.
2	Downregulation of miR-222 Induces Apoptosis and Cellular Migration in Adenoid Cystic Carcinoma Cells.Oncol Res. 2017 Jan 26;25(2):207-214. doi: 10.3727/096504016X14732772150460.
3	The mutational landscape of adenoid cystic carcinoma.Nat Genet. 2013 Jul;45(7):791-8. doi: 10.1038/ng.2643. Epub 2013 May 19.
4	Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum.J Clin Endocrinol Metab. 2006 Aug;91(8):2821-6. doi: 10.1210/jc.2005-2230. Epub 2006 May 16.
5	H-score of 11-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.Endocrine. 2019 Sep;65(3):683-691. doi: 10.1007/s12020-019-02022-8. Epub 2019 Jul 22.
6	Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.Cancer Genet. 2019 Jan;230:1-12. doi: 10.1016/j.cancergen.2018.10.005. Epub 2018 Nov 9.
7	Seladin-1 expression is regulated by promoter methylation in adrenal cancer.BMC Cancer. 2010 May 13;10:201. doi: 10.1186/1471-2407-10-201.
8	Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics.J Vis Exp. 2018 Mar 26;(133):56560. doi: 10.3791/56560.
9	SCFAs-Induced GLP-1 Secretion Links the Regulation of Gut Microbiome on Hepatic Lipogenesis in Chickens.Front Microbiol. 2019 Sep 26;10:2176. doi: 10.3389/fmicb.2019.02176. eCollection 2019.
10	Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx017.
11	Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.J Clin Endocrinol Metab. 2019 May 1;104(5):1712-1724. doi: 10.1210/jc.2018-01717.
12	Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.Int J Oncol. 2016 Jul;49(1):225-34. doi: 10.3892/ijo.2016.3532. Epub 2016 May 18.
13	Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess.Oncotarget. 2017 Dec 1;8(70):114736-114745. doi: 10.18632/oncotarget.22827. eCollection 2017 Dec 29.
14	Feminizing Adrenocortical Carcinoma: The Source of Estrogen Production and the Role of Adrenal-Gonadal Dedifferentiation.J Clin Endocrinol Metab. 2018 Oct 1;103(10):3706-3713. doi: 10.1210/jc.2018-00689.
15	Expression of PIM-1 in salivary gland adenoid cystic carcinoma: Association with tumor progression and patients' prognosis.Oncol Lett. 2018 Jan;15(1):1149-1156. doi: 10.3892/ol.2017.7408. Epub 2017 Nov 14.
16	Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumors.J Clin Endocrinol Metab. 2010 Dec;95(12):E421-9. doi: 10.1210/jc.2010-1100. Epub 2010 Sep 8.
17	Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma.Endocrinology. 2018 Aug 1;159(8):2836-2849. doi: 10.1210/en.2018-00014.
18	Competing Endogenous RNA Network Analysis Reveals Pivotal ceRNAs in Adrenocortical Carcinoma.Front Endocrinol (Lausanne). 2019 May 15;10:301. doi: 10.3389/fendo.2019.00301. eCollection 2019.
19	ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.Eur J Endocrinol. 2016 Jun;174(6):R249-65. doi: 10.1530/EJE-15-1118. Epub 2016 Jan 6.
20	Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2.J Neurol Sci. 2001 Feb 15;184(1):1-9. doi: 10.1016/s0022-510x(00)00497-4.
21	Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.J Med Genet. 2013 Apr;50(4):240-5. doi: 10.1136/jmedgenet-2012-101485. Epub 2013 Feb 7.
22	Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.J Trace Elem Med Biol. 2019 Dec;56:52-59. doi: 10.1016/j.jtemb.2019.07.009. Epub 2019 Jul 23.
23	High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.Int J Mol Sci. 2014 May 13;15(5):8393-406. doi: 10.3390/ijms15058393.
24	Novel de novo SPOCK1 mutation in a proband with developmental delay, microcephaly and agenesis of corpus callosum.Eur J Med Genet. 2014 Mar;57(4):181-4. doi: 10.1016/j.ejmg.2014.02.009. Epub 2014 Feb 27.
25	Identification of key modules and prognostic markers in adrenocortical carcinoma by weighted gene co-expression network analysis.Oncol Lett. 2019 Oct;18(4):3673-3681. doi: 10.3892/ol.2019.10725. Epub 2019 Aug 6.
26	Identification of acid-sensing ion channels in adenoid cystic carcinomas.Biochem Biophys Res Commun. 2007 Apr 20;355(4):986-92. doi: 10.1016/j.bbrc.2007.02.061. Epub 2007 Feb 20.
27	Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.Cancer Res. 1997 Sep 1;57(17):3772-8.
28	Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.Virchows Arch. 2009 Aug;455(2):133-42. doi: 10.1007/s00428-009-0807-x. Epub 2009 Jul 1.
29	A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma.Endocr Pathol. 2017 Dec;28(4):326-331. doi: 10.1007/s12022-017-9482-7.
30	Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.J Clin Endocrinol Metab. 2020 Jan 1;105(1):26-42. doi: 10.1210/clinem/dgz014.
31	Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.APMIS. 2014 May;122(5):418-26. doi: 10.1111/apm.12160. Epub 2013 Aug 13.
32	Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.Oncotarget. 2017 Feb 7;8(6):9323-9338. doi: 10.18632/oncotarget.14067.
33	Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22730-22736. doi: 10.1073/pnas.1911385116. Epub 2019 Oct 17.
34	Novel variants in CDH2 are associated with a new syndrome including Peters anomaly.Clin Genet. 2020 Mar;97(3):502-508. doi: 10.1111/cge.13660. Epub 2019 Nov 10.
35	Estrogen related receptor (ERR) a promising target for the therapy of adrenocortical carcinoma (ACC).Oncotarget. 2015 Sep 22;6(28):25135-48. doi: 10.18632/oncotarget.4722.
36	A novel 2q14.1q14.3 deletion involving GLI2 and RNU4ATAC genes associated with partial corpus callosum agenesis and severe intrauterine growth retardation.Birth Defects Res A Clin Mol Teratol. 2016 Sep;106(9):793-7. doi: 10.1002/bdra.23535. Epub 2016 Jun 27.
37	IGF2 role in adrenocortical carcinoma biology.Endocrine. 2019 Nov;66(2):326-337. doi: 10.1007/s12020-019-02033-5. Epub 2019 Aug 4.
38	A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.Genet Med. 2016 Nov;18(11):1090-1096. doi: 10.1038/gim.2016.1. Epub 2016 Mar 3.
39	Three cases with L1 syndrome and two novel mutations in the L1CAM gene.Eur J Pediatr. 2015 Nov;174(11):1541-4. doi: 10.1007/s00431-015-2560-2. Epub 2015 May 7.
40	Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.Clin Cancer Res. 2008 Jun 15;14(12):4016-24. doi: 10.1158/1078-0432.CCR-08-0106.
41	Agenesis of the corpus callosum in Nogo receptor deficient mice.J Comp Neurol. 2017 Feb 1;525(2):291-301. doi: 10.1002/cne.24064. Epub 2016 Jul 8.
42	Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma.J Exp Clin Cancer Res. 2014 Dec 31;33(1):114. doi: 10.1186/s13046-014-0114-5.
43	Mutations affecting GABAergic signaling in seizures and epilepsy. Pflugers Arch. 2010 Jul;460(2):505-23.
44	Topoisomerase 2 and thymidylate synthase expression in adrenocortical cancer.Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
45	AKT3 drives adenoid cystic carcinoma development in salivary glands.Cancer Med. 2018 Feb;7(2):445-453. doi: 10.1002/cam4.1293. Epub 2017 Dec 28.
46	Anti-hMC2RL1 Functionalized Gold Nanoparticles for Adrenocortical Tumor Cells Targeting and Imaging.J Biomed Nanotechnol. 2017 Jan;13(1):68-76. doi: 10.1166/jbn.2017.2331.
47	Novel ABCD1 Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum.Neurodegener Dis. 2018;18(2-3):156-164. doi: 10.1159/000490248. Epub 2018 Jul 2.
48	Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.Eur J Endocrinol. 2019 Feb 1;180(2):117-125. doi: 10.1530/EJE-18-0782.
49	ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Brain. 2016 Jan;139(Pt 1):73-85. doi: 10.1093/brain/awv320. Epub 2015 Nov 10.
50	Exercise-induced AMPK activation and IL-6 muscle production are disturbed in adiponectin knockout mice.Cytokine. 2019 Jul;119:71-80. doi: 10.1016/j.cyto.2019.03.009. Epub 2019 Mar 20.
51	Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.Ann Surg. 2008 Jan;247(1):157-64. doi: 10.1097/SLA.0b013e318153ff55.
52	Corpus callosum metrics predict severity of visuospatial and neuromotor dysfunctions in ARID1B mutations with Coffin-Siris syndrome.Psychiatr Genet. 2019 Dec;29(6):237-242. doi: 10.1097/YPG.0000000000000225.
53	Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.
54	BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/-Catenin Activating Event Driving Adrenocortical Malignancy.J Am Coll Surg. 2018 Jun;226(6):988-995. doi: 10.1016/j.jamcollsurg.2018.01.051. Epub 2018 Feb 8.
55	Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma.Clin Cancer Res. 2019 Jun 1;25(11):3276-3288. doi: 10.1158/1078-0432.CCR-18-2693. Epub 2019 Feb 15.
56	Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
57	POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells.Mol Cell Endocrinol. 2013 May 22;371(1-2):140-7. doi: 10.1016/j.mce.2012.12.029. Epub 2013 Jan 9.
58	Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.Surgery. 2004 Dec;136(6):1122-8. doi: 10.1016/j.surg.2004.06.041.
59	Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis.Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22269-22274. doi: 10.1073/pnas.1912700116. Epub 2019 Oct 14.
60	Transcription Dynamics Prevent RNA-Mediated Genomic Instability through SRPK2-Dependent DDX23 Phosphorylation.Cell Rep. 2017 Jan 10;18(2):334-343. doi: 10.1016/j.celrep.2016.12.050.
61	Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review.Schizophr Res. 2013 Jun;147(1):1-13. doi: 10.1016/j.schres.2013.03.015. Epub 2013 Apr 16.
62	Advanced adenoid cystic carcinoma (ACC) is featured by SWI/SNF chromatin remodeling complex aberrations.J Cancer Res Clin Oncol. 2019 Jan;145(1):201-211. doi: 10.1007/s00432-018-2783-5. Epub 2018 Oct 31.
63	Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma.Cancer. 2012 Mar 1;118(5):1288-92. doi: 10.1002/cncr.26412. Epub 2011 Jul 28.
64	Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused by EGP5 mutation.Am J Med Genet A. 2017 Mar;173(3):706-711. doi: 10.1002/ajmg.a.38061. Epub 2017 Feb 7.
65	The Prognostic Significance of Notch1 and Fatty Acid Binding Protein 7 (FABP7) Expression in Resected Tracheobronchial Adenoid Cystic Carcinoma: A Multicenter Retrospective Study.Cancer Res Treat. 2018 Oct;50(4):1064-1073. doi: 10.4143/crt.2017.337. Epub 2017 Nov 15.
66	FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria.EMBO Rep. 2016 Sep;17(9):1264-80. doi: 10.15252/embr.201541504. Epub 2016 Jul 11.
67	FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections.Neuron. 2018 Dec 5;100(5):1083-1096.e5. doi: 10.1016/j.neuron.2018.10.016. Epub 2018 Nov 1.
68	Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.Cancer Sci. 2011 Feb;102(2):492-7. doi: 10.1111/j.1349-7006.2010.01787.x. Epub 2010 Nov 24.
69	Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.J Clin Endocrinol Metab. 2015 Mar;100(3):E493-502. doi: 10.1210/jc.2014-3282. Epub 2014 Dec 9.
70	Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.Am J Surg Pathol. 2015 Oct;39(10):1347-56. doi: 10.1097/PAS.0000000000000463.
71	Immunohistochemical and molecular profile of salivary gland cancer in children.Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26468. Epub 2017 Jan 31.
72	Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/-catenin signaling pathway and the epithelial-mesenchymal transition process.Biol Chem. 2018 May 24;399(6):593-602. doi: 10.1515/hsz-2017-0304.
73	MKS1 mutations cause Joubert syndrome with agenesis of the corpus callosum.Eur J Med Genet. 2016 Aug;59(8):386-91. doi: 10.1016/j.ejmg.2016.06.007. Epub 2016 Jul 1.
74	Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness.J Clin Endocrinol Metab. 2012 May;97(5):E747-54. doi: 10.1210/jc.2011-2328. Epub 2012 Mar 14.
75	Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.Am J Pathol. 2013 Jun;182(6):2048-57. doi: 10.1016/j.ajpath.2013.02.020. Epub 2013 Apr 10.
76	Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.Oncol Rep. 2013 Dec;30(6):2659-64. doi: 10.3892/or.2013.2738. Epub 2013 Sep 19.
77	The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.Mol Cell Biochem. 2014 Nov;396(1-2):175-85. doi: 10.1007/s11010-014-2153-9. Epub 2014 Aug 1.
78	RARRES2 functions as a tumor suppressor by promoting -catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.Oncogene. 2017 Jun 22;36(25):3541-3552. doi: 10.1038/onc.2016.497. Epub 2017 Jan 23.
79	The role of primary cilia in corpus callosum formation is mediated by production of the Gli3 repressor.Hum Mol Genet. 2015 Sep 1;24(17):4997-5014. doi: 10.1093/hmg/ddv221. Epub 2015 Jun 12.
80	Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma.PLoS One. 2012;7(11):e48582. doi: 10.1371/journal.pone.0048582. Epub 2012 Nov 7.
81	Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.Eur J Endocrinol. 2017 Nov;177(5):439-444. doi: 10.1530/EJE-17-0358. Epub 2017 Aug 17.
82	Reciprocal interplay of miR-497 and MALAT1 promotes tumourigenesis of adrenocortical cancer.Endocr Relat Cancer. 2019 Jul;26(7):677-688. doi: 10.1530/ERC-19-0036.
83	Knockdown of SKA1 gene inhibits cell proliferation and metastasis in human adenoid cystic carcinoma.Biomed Pharmacother. 2017 Jun;90:8-14. doi: 10.1016/j.biopha.2017.03.029. Epub 2017 Mar 21.
84	Whole exome sequencing of adenoid cystic carcinoma.J Clin Invest. 2013 Jul;123(7):2965-8. doi: 10.1172/JCI67201. Epub 2013 Jun 17.
85	Interstitial 1p32.1p32.3 deletion in a patient with multiple congenital anomalies.Am J Med Genet A. 2015 Oct;167A(10):2406-10. doi: 10.1002/ajmg.a.37178. Epub 2015 Jun 10.
86	An Emerging Female Phenotype with Loss-of-Function Mutations in the Aristaless-Related Homeodomain Transcription Factor ARX.Hum Mutat. 2017 May;38(5):548-555. doi: 10.1002/humu.23190. Epub 2017 Feb 15.
87	A novel heterozygous loss-of-function DCC Netrin 1 receptor variant in prenatal agenesis of corpus callosum and review of the literature.Am J Med Genet A. 2020 Jan;182(1):205-212. doi: 10.1002/ajmg.a.61404. Epub 2019 Nov 7.
88	High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin.Jpn J Cancer Res. 1999 Mar;90(3):308-19. doi: 10.1111/j.1349-7006.1999.tb00749.x.
89	Nuclear factor I X deficiency causes brain malformation and severe skeletal defects. Mol Cell Biol. 2007 May;27(10):3855-3867. doi: 10.1128/MCB.02293-06.
90	Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome.Free Radic Biol Med. 2019 Apr;134:119-132. doi: 10.1016/j.freeradbiomed.2019.01.011. Epub 2019 Jan 10.
91	Clinical and biochemical features guiding the diagnostics in neurometabolic cutis laxa. Eur J Hum Genet. 2014 Jul;22(7):888-95. doi: 10.1038/ejhg.2013.154. Epub 2013 Aug 21.
92	Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma.Br J Cancer. 2004 Sep 13;91(6):1131-8. doi: 10.1038/sj.bjc.6602004.
93	Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.Eur J Hum Genet. 2018 May;26(5):695-708. doi: 10.1038/s41431-018-0098-2. Epub 2018 Feb 20.
94	Elucidating the genetic architecture of Adams-Oliver syndrome in a large European cohort.Hum Mutat. 2018 Sep;39(9):1246-1261. doi: 10.1002/humu.23567. Epub 2018 Jul 4.
95	An update on adrenal endocrinology: significant discoveries in the last 10years and where the field is heading in the next decade.Hormones (Athens). 2018 Dec;17(4):479-490. doi: 10.1007/s42000-018-0072-y. Epub 2018 Nov 19.
96	Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B. N Engl J Med. 2016 Dec 1;375(22):2165-2176. doi: 10.1056/NEJMoa1509164.
97	A homozygous deleterious CDK10 mutation in a patient with agenesis of corpus callosum, retinopathy, and deafness.Am J Med Genet A. 2018 Jan;176(1):92-98. doi: 10.1002/ajmg.a.38506. Epub 2017 Nov 12.
98	EARS2 mutations cause fatal neonatal lactic acidosis, recurrent hypoglycemia and agenesis of corpus callosum.Metab Brain Dis. 2016 Jun;31(3):717-21. doi: 10.1007/s11011-016-9793-2. Epub 2016 Jan 16.
99	Prenatal diagnosis in a family with X-linked hydrocephalus.Prenat Diagn. 2005 Oct;25(10):930-3. doi: 10.1002/pd.1228.
100	Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?.Endocrine. 2017 Nov;58(2):276-288. doi: 10.1007/s12020-017-1409-z. Epub 2017 Sep 8.
101	Frameshift mutation of the zinc finger homeo box 1 B gene in syndromic corpus callosum agenesis (Mowat-Wilson syndrome).Neuropediatrics. 2003 Dec;34(6):322-5. doi: 10.1055/s-2003-44671.
102	Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.PLoS One. 2014 Aug 11;9(8):e104944. doi: 10.1371/journal.pone.0104944. eCollection 2014.
103	De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.Am J Med Genet A. 2012 Sep;158A(9):2272-6. doi: 10.1002/ajmg.a.35490. Epub 2012 Jul 27.
104	MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.Oral Oncol. 2019 Nov;98:147-155. doi: 10.1016/j.oraloncology.2019.09.005. Epub 2019 Oct 10.
105	Steroid Receptor Coactivator-1 Expression in Pheochromocytoma: Clinicopathologic Correlation and Potential Diagnostic Pitfall.Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):761-766. doi: 10.1097/PAI.0000000000000815.
106	MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.Int J Cancer. 2018 Aug 15;143(4):944-957. doi: 10.1002/ijc.31363. Epub 2018 Mar 30.
107	Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery.Nat Commun. 2018 Oct 10;9(1):4183. doi: 10.1038/s41467-018-06571-w.
108	PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.Neurobiol Dis. 2020 Mar;136:104709. doi: 10.1016/j.nbd.2019.104709. Epub 2019 Dec 14.
109	Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.Cells. 2017 Nov 7;6(4):42. doi: 10.3390/cells6040042.
110	A de novo mutation in PRICKLE1 in fetal agenesis of the corpus callosum and polymicrogyria.J Neurogenet. 2015;29(4):174-7. doi: 10.3109/01677063.2015.1088847. Epub 2016 Jan 4.
111	High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.J Clin Endocrinol Metab. 2010 Oct;95(10):E161-71. doi: 10.1210/jc.2010-0653. Epub 2010 Jul 21.
112	Clinical, pathological and treatment factors associated with the survival of patients with primary pulmonary salivary gland-type tumors.Lung Cancer. 2018 Dec;126:174-181. doi: 10.1016/j.lungcan.2018.11.010. Epub 2018 Nov 10.
113	Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity. Nat Genet. 2016 Aug;48(8):877-87. doi: 10.1038/ng.3619. Epub 2016 Jul 11.
114	Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.Clin Breast Cancer. 2017 Jul;17(4):298-306.e7. doi: 10.1016/j.clbc.2017.01.007. Epub 2017 Jan 27.
115	Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.Am J Pathol. 2002 Oct;161(4):1315-23. doi: 10.1016/S0002-9440(10)64408-2.
116	The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat.Nat Genet. 2006 Feb;38(2):191-6. doi: 10.1038/ng1713. Epub 2006 Jan 15.